436 related articles for article (PubMed ID: 23850736)
1. 3D organotypic HepaRG cultures as in vitro model for acute and repeated dose toxicity studies.
Mueller D; Krämer L; Hoffmann E; Klein S; Noor F
Toxicol In Vitro; 2014 Feb; 28(1):104-12. PubMed ID: 23850736
[TBL] [Abstract][Full Text] [Related]
2. 3D organotypic cultures of human HepaRG cells: a tool for in vitro toxicity studies.
Gunness P; Mueller D; Shevchenko V; Heinzle E; Ingelman-Sundberg M; Noor F
Toxicol Sci; 2013 May; 133(1):67-78. PubMed ID: 23377618
[TBL] [Abstract][Full Text] [Related]
3. Comparison of Drug Metabolism and Its Related Hepatotoxic Effects in HepaRG, Cryopreserved Human Hepatocytes, and HepG2 Cell Cultures.
Yokoyama Y; Sasaki Y; Terasaki N; Kawataki T; Takekawa K; Iwase Y; Shimizu T; Sanoh S; Ohta S
Biol Pharm Bull; 2018 May; 41(5):722-732. PubMed ID: 29445054
[TBL] [Abstract][Full Text] [Related]
4. HepaRG culture in tethered spheroids as an in vitro three-dimensional model for drug safety screening.
Wang Z; Luo X; Anene-Nzelu C; Yu Y; Hong X; Singh NH; Xia L; Liu S; Yu H
J Appl Toxicol; 2015 Aug; 35(8):909-17. PubMed ID: 25512232
[TBL] [Abstract][Full Text] [Related]
5. Human Hepatic HepaRG Cells Maintain an Organotypic Phenotype with High Intrinsic CYP450 Activity/Metabolism and Significantly Outperform Standard HepG2/C3A Cells for Pharmaceutical and Therapeutic Applications.
Nelson LJ; Morgan K; Treskes P; Samuel K; Henderson CJ; LeBled C; Homer N; Grant MH; Hayes PC; Plevris JN
Basic Clin Pharmacol Toxicol; 2017 Jan; 120(1):30-37. PubMed ID: 27285124
[TBL] [Abstract][Full Text] [Related]
6. Three-dimensional HepaRG model as an attractive tool for toxicity testing.
Leite SB; Wilk-Zasadna I; Zaldivar JM; Airola E; Reis-Fernandes MA; Mennecozzi M; Guguen-Guillouzo C; Chesne C; Guillou C; Alves PM; Coecke S
Toxicol Sci; 2012 Nov; 130(1):106-16. PubMed ID: 22843569
[TBL] [Abstract][Full Text] [Related]
7. 3D-bioprinted HepaRG cultures as a model for testing long term aflatoxin B1 toxicity
Schmidt K; Berg J; Roehrs V; Kurreck J; Al-Zeer MA
Toxicol Rep; 2020; 7():1578-1587. PubMed ID: 33304827
[TBL] [Abstract][Full Text] [Related]
8. HepaRG-Progenitor Cell Derived Hepatocytes Cultured in Bioartificial Livers Are Protected from Healthy- and Acute Liver Failure-Plasma Induced Toxicity.
van Wenum M; Treskes P; Adam AAA; van der Mark VA; Jongejan A; Moerland PD; van Gulik TM; Oude Elferink RPJ; Chamuleau RAFM; Hoekstra R
Cell Physiol Biochem; 2018; 48(5):2189-2204. PubMed ID: 30110678
[TBL] [Abstract][Full Text] [Related]
9. Bioprinted 3D Primary Liver Tissues Allow Assessment of Organ-Level Response to Clinical Drug Induced Toxicity In Vitro.
Nguyen DG; Funk J; Robbins JB; Crogan-Grundy C; Presnell SC; Singer T; Roth AB
PLoS One; 2016; 11(7):e0158674. PubMed ID: 27387377
[TBL] [Abstract][Full Text] [Related]
10. Long-term functional stability of human HepaRG hepatocytes and use for chronic toxicity and genotoxicity studies.
Jossé R; Aninat C; Glaise D; Dumont J; Fessard V; Morel F; Poul JM; Guguen-Guillouzo C; Guillouzo A
Drug Metab Dispos; 2008 Jun; 36(6):1111-8. PubMed ID: 18347083
[TBL] [Abstract][Full Text] [Related]
11. Characterization of primary human hepatocytes, HepG2 cells, and HepaRG cells at the mRNA level and CYP activity in response to inducers and their predictivity for the detection of human hepatotoxins.
Gerets HH; Tilmant K; Gerin B; Chanteux H; Depelchin BO; Dhalluin S; Atienzar FA
Cell Biol Toxicol; 2012 Apr; 28(2):69-87. PubMed ID: 22258563
[TBL] [Abstract][Full Text] [Related]
12. Integration of in vitro data from three dimensionally cultured HepaRG cells and physiologically based pharmacokinetic modeling for assessment of acetaminophen hepatotoxicity.
Zhang C; Zhang Q; Li J; Yu L; Li F; Li W; Li Y; Peng H; Zhao J; Carmichael PL; Wang Y; Peng S; Guo J
Regul Toxicol Pharmacol; 2020 Jul; 114():104661. PubMed ID: 32315674
[TBL] [Abstract][Full Text] [Related]
13. Type of endothelial cells affects HepaRG cell acetaminophen metabolism in both 2D and 3D porous scaffold cultures.
German CL; Madihally SV
J Appl Toxicol; 2019 Mar; 39(3):461-472. PubMed ID: 30307041
[TBL] [Abstract][Full Text] [Related]
14. Long-term and mechanistic evaluation of drug-induced liver injury in Upcyte human hepatocytes.
Tolosa L; Jiménez N; Pelechá M; Castell JV; Gómez-Lechón MJ; Donato MT
Arch Toxicol; 2019 Feb; 93(2):519-532. PubMed ID: 30426164
[TBL] [Abstract][Full Text] [Related]
15. Long-term maintenance of HepaRG cells in serum-free conditions and application in a repeated dose study.
Klein S; Mueller D; Schevchenko V; Noor F
J Appl Toxicol; 2014 Oct; 34(10):1078-86. PubMed ID: 24114766
[TBL] [Abstract][Full Text] [Related]
16. Overexpression of the constitutive androstane receptor and shaken 3D-culturing increase biotransformation and oxidative phosphorylation and sensitivity to mitochondrial amiodarone toxicity of HepaRG cells.
van der Mark VA; Adam AAA; Chang JC; Oude Elferink RP; Chamuleau RAFM; Hoekstra R
Toxicol Appl Pharmacol; 2020 Jul; 399():115055. PubMed ID: 32428594
[TBL] [Abstract][Full Text] [Related]
17. Phase 1 and phase 2 drug metabolism and bile acid production of HepaRG cells in a bioartificial liver in absence of dimethyl sulfoxide.
Hoekstra R; Nibourg GA; van der Hoeven TV; Plomer G; Seppen J; Ackermans MT; Camus S; Kulik W; van Gulik TM; Elferink RP; Chamuleau RA
Drug Metab Dispos; 2013 Mar; 41(3):562-7. PubMed ID: 23238784
[TBL] [Abstract][Full Text] [Related]
18. Baseline and genotoxic compound induced gene expression profiles in HepG2 and HepaRG compared to primary human hepatocytes.
Jetten MJ; Kleinjans JC; Claessen SM; Chesné C; van Delft JH
Toxicol In Vitro; 2013 Oct; 27(7):2031-40. PubMed ID: 23911569
[TBL] [Abstract][Full Text] [Related]
19. Advanced In Vitro HepaRG Culture Systems for Xenobiotic Metabolism and Toxicity Characterization.
Ashraf MN; Asghar MW; Rong Y; Doschak MR; Kiang TKL
Eur J Drug Metab Pharmacokinet; 2019 Aug; 44(4):437-458. PubMed ID: 30535757
[TBL] [Abstract][Full Text] [Related]
20. In Silico Modeling for the Prediction of Dose and Pathway-Related Adverse Effects in Humans From In Vitro Repeated-Dose Studies.
Klein S; Maggioni S; Bucher J; Mueller D; Niklas J; Shevchenko V; Mauch K; Heinzle E; Noor F
Toxicol Sci; 2016 Jan; 149(1):55-66. PubMed ID: 26420750
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
